Literature DB >> 21959065

[Clinical management of patient with benign prostatic hyperplasia in Spain].

J M Cozar1, E Solsona, F Brenes, A Fernández-Pro, F León, J M Molero, J F Pérez, M P Rodríguez, A Huerta, I Pérez-Escolano.   

Abstract

OBJECTIVES: To identify clinical management of benign prostatic hyperplasia (BPH) in Spain and its associated health care resources.
MATERIAL AND METHODS: A qualitative cross-sectional study was conducted through telephone interviews to general practitioners (GP) and urologists. Information about diagnosis, pharmacologic treatment and follow-up was collected. Results were clustered according to the key variables considered as drivers of clinical practice patterns: BPH diagnosis, severity classification, treatment initiation and follow up of patients.
RESULTS: 153 GP and 154 urologists participated in the study. 7 different clinical patterns were identified in primary care (PC). Resource use during diagnosis is relatively homogeneous, reporting a range of 2.0 to 2.6 visits employed and being the most frequent test performed PSA and urine test. Follow-up is heterogeneous; frequency of follow-up visits oscillates from 3.2 to 7.0 visits/patient/year and type of tests performed is different among patterns and within the same pattern. In Urology, 3 clinical patterns were identified. Resource use is homogeneous in the diagnosis and in the follow-up; urologists employed 2 visits in diagnosis and a range of 2.1 to 3.2 visits/patient/year in the follow-up. The most frequent tests both in diagnosis and follow-up are PSA and digital test.
CONCLUSIONS: BPH management shows variability in PC, identifying 7 different clinical practice patterns with different resource use during the follow-up among patterns and within the same pattern. The implementation of clinical guidelines could be justified to reduce heterogeneity.
Copyright © 2011 AEU. Published by Elsevier Espana. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21959065     DOI: 10.1016/j.acuro.2011.07.008

Source DB:  PubMed          Journal:  Actas Urol Esp        ISSN: 0210-4806            Impact factor:   0.994


  3 in total

1.  Effects of low-frequency ultrasound combined with microbubbles on benign prostate hyperplasia.

Authors:  Shao-Ling Yang; Ke-Qiang Tang; Wen-Kun Bai; E Shen; Yi-Wen Zhao; Yan-Duan Lin; Shu-Liang Nan; Hu Bing
Journal:  Can Urol Assoc J       Date:  2013 Nov-Dec       Impact factor: 1.862

2.  Combined low-frequency ultrasound and microbubble contrast agent for the treatment of benign prostatic hyperplasia.

Authors:  Shao-ling Yang; Ke-qiang Tang; Wen-kun Bai; Yi-Wen Zhao; E Shen; Jun-jia Tao; Bing Hu
Journal:  J Endourol       Date:  2013-08       Impact factor: 2.942

3.  [Quality of care indicators for benign prostatic hyperplasia. A qualitative study].

Authors:  Jorge Navarro-Pérez; Salvador Peiró; Francisco Brotons-Muntó; Emilio López-Alcina; Arcadio Real-Romaguera
Journal:  Aten Primaria       Date:  2013-12-15       Impact factor: 1.137

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.